LU-CID - News Feed

Schistosoma haematobium Glycomics Paper

laurienbakker — Tue, 19 May 2026 11:59:00 +0200

This month, the Glycoscience and Helminth infections research group published a significant paper in Nature Communications which has implications regarding the way that we diagnose schistosomiasis, a neglected tropical disease.

Dr. Rajagopal Murugan awarded the Boehringer Ingelheim Award

laurienbakker — Tue, 19 May 2026 11:03:00 +0200

Ahead of the Dutch Society of Parasitology's Spring scientific meeting, the recipient of the Boehringer Ingelheim Award for Parasitology 2026 has been announced as Dr. Rajagopal Murugan!

Microbiome Analysis Tool in Nature Microbiology

laurienbakker — Wed, 13 May 2026 15:07:00 +0200

Ancient Greek philosopher Hippocrates famously said, “All disease begins in the gut”. Two thousand years later, LUCID researchers are studying the human microbiome to understand whether he was correct and why, by looking into the molecular mechanisms that drive disease, from colorectal cancer to IBD, to mental illness. It all comes down to the complex ecosystem of bacteria and their interactions with host cells in the gut, says Prof. Georg Zeller.

LUCID Meeting Day

laurienbakker — Tue, 12 May 2026 13:36:00 +0200

Once a year, we take time out of our day-to-day work to come together, learn from one another, and identify ways to make LUCID even better as a department.

Prof. Meta Roestenberg Appointed to KNAW

laurienbakker — Tue, 12 May 2026 11:21:00 +0200

For her work on malaria vaccine research, LUCID head Prof. Meta Roesteberg has been elected as a member of the Royal Netherlands Academy of Sciences (KNAW), one of the highest scientific institutions in the Netherlands.

MUSICC Annual Meeting Rotterdam

laurienbakker — Thu, 30 Apr 2026 09:30:00 +0200

Together with colleagues from @LUMC Center for Cell and Gene Therapy (CCG), members of LUCID Research travelled to Rotterdam last week for the third Mucosal Immunity in Human Coronavirus Challenge (MUSICC) annual meeting.

Strengthening Leiden-Brazil schistosomiasis research collaboration

frederikepeters — Thu, 16 Apr 2026 09:21:00 +0200

Recently, Govert van Dam and Pytsje Hoekstra had the pleasure of welcoming André Daher from FIOCRUZ – Fundação Oswaldo Cruz (Brazil) to Leiden to discuss collaborations on schistosomiasis research. The visit focused on ongoing work with Fiocruz and aimed to further strengthen the connection between our teams in Brazil and Leiden.

GLYCELL project awarded ZonMW Open Competition

frederikepeters — Mon, 13 Apr 2026 10:17:00 +0200

The GLYCELL project led by Bruno Guigas (LUCID-R), in collaboration with Noortje de Haan (LUMC, CPM) and Onno Holleboom (AUMC), is one of the 31 research projects awarded this year for the ZonMW Open Competition program, with approximately €900,000 allocated to LUMC.

LUCID at NVMM/KNVM Spring meeting

frederikepeters — Wed, 08 Apr 2026 12:39:00 +0200

At the start of this month, the annual Spring meeting of the Dutch Society of Medical Microbiology (NVMM) and the Royal Dutch Society of Microbiology (KNVM) took place, with contributions from LUCID!

Mariet Feltkamp appointed professor in Medical Microbiology

frederikepeters — Fri, 03 Apr 2026 09:11:00 +0200

Mariet Feltkamp has been appointed endowed professor of Medical Microbiology, with a focus on preventing the transmission of viral infections through blood transfusion and organ transplantation. Her chair connects Leiden University Medical Center (LUMC) and Sanquin Blood Supply. This dual position reflects the breadth of her work, which ranges from selecting and testing donors to improving the resilience of transplant recipients.

Annemieke Geluk awarded Eijkman medal 2026

frederikepeters — Mon, 09 Mar 2026 13:41:00 +0100

Prof Dr Annemieke Geluk, LUCID-R, LUMC, has been awarded the 2026 Eijkman Medal in recognition of her outstanding contributions to global health! The Eijkman medal is awarded once every 2 years by the Royal Tropical Institute (KIT) to someone whom has contributed strongly to tropical or global health, in particular in low and middle income countries.

PhD Defence: Josiane Honkpehedji

frederikepeters — Wed, 04 Mar 2026 11:18:00 +0100

On the 3rd of March we celebrated Josiane Honkpéhèdji's successful defence of her thesis, titled: 'Endemic parasitic infections during pregnancy and their impact on clinical and immunological outcomes in Gabon'. She completed her PhD under supervision of prof. Yazdanbakhsh, prof. Hokke and prof. Adegnika (CERMEL).

Horizon Europe funding for REPHRAME consortium

frederikepeters — Thu, 26 Feb 2026 12:04:00 +0100

The REPHRAME consortium proposal, including Georg Zeller and Merel Lambregts from LUCID, has been awarded Horizon Europe funding under the HORIZON‑HLTH ‑2025‑01‑DISEASE‑01 call, with approximately €750,000 allocated to LUMC.

Pneumonia study with Malawi collaborators

frederikepeters — Sun, 15 Feb 2026 11:27:00 +0100

LUCID researchers dr. Dennis Hoving, Alicia de Kroon, dr. Simon Jochems, and Godwin Tembo at the Malawi Liverpool Wellcome Research Programme, studied how adults in Malawi respond to PCV13. This vaccine protects against multiple types of pneumococcal bacteria that can cause pneumonia and other serious infections. Although the vaccine has reduced disease overall, one type (serotype 3) continues to spread, especially in high-transmission settings.